Cosentyx patient reviews?

Why are patients taking Cosentyx?

Patients take Cosentyx primarily for moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Many reviewers mention relief from joint pain and skin plaques after failing other treatments.

What side effects are patients reporting?

Patients describe fatigue, injection site reactions, upper respiratory infections, and diarrhea as common complaints. Some also report increased susceptibility to infections, including candida, after several doses. A minority mention hair thinning or mood changes.

Can Cosentyx clear skin faster than other biologics?

Some reviewers say Cosentyx produces noticeable skin improvement within weeks rather than months. Others report that their skin stayed clear for months after stopping the drug, but this experience varies widely.

How long does Cosentyx stay in the system?

The half-life of Cosentyx is roughly 25 to 26 days. Once discontinued, patients say it takes two to three months before symptoms begin to return.

What happens if you miss a dose?

Patients who missed a single dose report no immediate jump in symptoms. Those who missed two or more consecutive doses often see partial relapse of skin or joint pain. Reviewers recommend scheduling reminders to keep consistency.

Why are companies challenging this patent?

Novartis holds the patent on Cosentyx (secukinumab) through March 2027. Competitors are already seeking to develop biosimilars and patent challenges are underway.